Dr. Edward Chong, MBChB, MRCP, Dip Pharm Med

Chief Medical Officer

Dr. Chong is a physician with over 25 years of drug development experience in the pharmaceutical industry. During this period, he has worked in large and small pharmaceutical companies and across several therapeutic areas. He has achieved a track record of designing and implementing global clinical development programs resulting in several successful regulatory submissions in the USA and Europe.‚Äč

Prior to this role, Dr. Chong served as Vice President, Clinical Research at Aspreva Pharmaceuticals, and then subsequent to its sale, as Vice President responsible for global clinical research and biometrics at Vifor Pharma. Dr. Chong received his undergraduate medical education and post-graduate training in internal medicine and cardiology in the Universities of Dundee and Glasgow, Scotland.

Vitaeris is now part of CSL Behring! We are pleased to become part of CSL Behring, a well-established, global industry leader, and know that the future of clazakizumab is in excellent hands. Together, we have already achieved much progress through our partnership over the past few years and are now in an even stronger position to realize our collective goal of addressing one of the greatest unmet needs in the organ transplant community.

Learn more